Position in TEVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$41,604
New position
Shares Held
1,228
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#541
of 671 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Elequin Capital, LP holds $7,829,403 across 8 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
223,068 | $7,733,767 | |
| 2 | HLN |
Haleon plc
|
5,397 | $50,354 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
1,228 | $41,604 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
26 | $2,152 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
24 | $608 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
10 | $410 | |
| 7 | ZTS |
Zoetis Inc.
|
4 | $287 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
11 | $221 |
All Filings in TEVA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,604 | 1,228 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||